Explain this page
Arphra AIPlain-English read on Newmont Corporation’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Quality composite
A+Top tier
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Profitability
Gross margin49.8%
Operating margin46.9%
Net margin32.1%
ROE20.8%
ROA12.4%
ROIC19.6%
Liquidity & leverage
Current ratio2.29×
Quick ratio1.82×
Debt / equity0.17×
Net debt / EBITDA-0.15×
Interest coverage34×
Efficiency & per-share
Asset turnover0.39×
Inventory days88
Days sales out.29
FCF / share$6.59
Book value / share$30.72
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | $42.65B | $110.43B | — | — | — | — |
| Enterprise value | — | — | — | $48.01B | $108.5B | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | 2.59 | 4.91 | — | — | — | — |
| EV / FCF | — | — | — | 16.21 | 14.86 | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | +7.85% | +6.42% | — | — | — | — |
| Free cash flow yield | — | — | — | +6.94% | +6.61% | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +19.49% | +17.94% | +9.94% | +34.62% | +49.78% | +32.14% | +30.61% | +32.08% | +32.02% |
| Operating margin | +15.72% | +13.57% | +5.52% | +30.97% | +46.85% | +27.59% | +28.14% | +28.38% | +27.91% |
| EBITDA margin | +45.47% | +27.47% | +15.78% | +42.39% | +59.39% | +39.81% | +39.46% | +38.70% | +40.26% |
| EBIT margin | +11.27% | +1.47% | -15.14% | +26.74% | +46.85% | +19.32% | +19.65% | +19.62% | +19.17% |
| Pre-tax margin | +10.45% | +0.47% | -16.71% | +25.38% | +53.23% | +21.15% | +20.98% | +20.27% | +21.06% |
| Net margin | +9.57% | -3.84% | -21.41% | +18.04% | +32.06% | +9.72% | +9.69% | +9.71% | +9.79% |
| Cost structure | |||||||||
| Cost of revenue / sales | +80.51% | +82.06% | +90.06% | +65.38% | +50.22% | +67.23% | +68.61% | +66.67% | +67.03% |
| R&D intensity | +1.26% | +1.92% | +1.70% | +1.06% | +0.75% | +1.16% | +1.17% | +1.18% | +1.15% |
| SG&A intensity | +2.12% | +2.31% | +2.54% | +2.38% | +1.73% | +2.21% | +2.22% | +2.23% | +2.24% |
| Effective tax rate | +86.19% | +812.50% | — | +29.66% | +39.07% | +32.75% | +34.16% | +34.13% | +33.16% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +5.33% | -2.35% | -8.63% | +11.12% | +20.81% | +5.09% | +5.00% | +4.98% | +5.26% |
| Return on assets (ROA) | +2.87% | -1.19% | -4.54% | +5.94% | +12.40% | +2.80% | +2.77% | +2.90% | +2.80% |
| Return on capital (ROC) | +6.80% | +6.32% | +1.68% | +14.71% | +26.04% | +11.32% | +11.41% | +11.55% | +11.82% |
| Return on invested capital (ROIC) | +4.14% | +4.74% | +1.26% | +8.57% | +17.82% | +3.99% | +3.93% | +3.95% | +4.15% |
| Asset turnover | +30.05% | +31.05% | +21.21% | +32.93% | +38.68% | +28.81% | +28.58% | +29.87% | +28.57% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +9.57% | -3.84% | -21.41% | +18.04% | +32.06% | +9.72% | +9.69% | +9.71% | +9.79% |
| Asset turnover (× revenue / assets) | +30.05% | +31.05% | +21.21% | +32.93% | +38.68% | +28.81% | +28.58% | +29.87% | +28.57% |
| Equity multiplier (× assets / equity) | +185.55% | +197.01% | +190.06% | +187.15% | +167.80% | +181.85% | +180.46% | +171.85% | +188.12% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 0.30 | 0.31 | 0.21 | 0.33 | 0.39 | 0.29 | 0.29 | 0.30 | 0.29 |
| Fixed-asset turnover | 0.51 | 0.50 | 0.31 | 0.55 | 0.66 | — | — | — | — |
| Inventory turnover | 5.49 | 5.59 | 4.01 | 5.56 | 4.13 | — | — | — | — |
| Receivables turnover | 36.17 | 17.32 | 9.60 | 17.57 | 12.66 | — | — | — | — |
| Payables turnover | 18.95 | 15.49 | 11.05 | 14.39 | 13.60 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 10.09 | 21.08 | 38.03 | 20.77 | 28.82 | — | — | — | — |
| Days inventory outstanding (DIO) | 66.46 | 65.26 | 90.93 | 65.70 | 88.44 | — | — | — | — |
| Days payables outstanding (DPO) | 19.27 | 23.56 | 33.04 | 25.36 | 26.84 | — | — | — | — |
| Cash conversion cycle | 57.29 | 62.77 | 95.93 | 61.11 | 90.42 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 3.67 | -7.02 | -1.10 | 1.90 | 1.46 | 3.63 | 3.70 | 3.60 | 3.49 |
| FCF / Net income | 2.25 | -2.37 | -0.04 | 0.88 | 1.03 | 1.76 | 1.68 | 1.76 | 1.66 |
| FCF margin | +21.54% | +9.11% | +0.82% | +15.96% | +33.03% | +17.07% | +16.24% | +17.05% | +16.29% |
| OCF margin | +35.10% | +26.95% | +23.46% | +34.29% | +46.77% | +35.26% | +35.86% | +34.89% | +34.22% |
| CapEx / Revenue | +13.56% | +17.83% | +22.64% | +18.33% | +13.73% | +18.18% | +18.41% | +18.32% | +18.59% |
| CapEx / D&A | 0.71 | 0.98 | 1.26 | 1.32 | 1.20 | — | — | — | — |
| Stock-based comp / Revenue | +0.59% | +0.61% | +0.68% | +0.48% | +0.45% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 1.46 | -0.58 | -3.00 | 2.86 | 6.41 | 10.28 | 11.42 | 12.48 | 11.92 |
| EPS · basic | 1.46 | -0.58 | -3.00 | 2.86 | 6.41 | 10.17 | 11.43 | 12.62 | 11.95 |
| Book value / share | 27.29 | 24.57 | 34.73 | 26.23 | 30.72 | 48.81 | 53.34 | 54.03 | 53.20 |
| Tangible BV / share | 23.83 | 22.09 | 31.16 | 23.91 | 28.32 | 48.81 | 53.34 | 54.03 | 53.20 |
| Sales / share | 15.22 | 15.03 | 14.00 | 16.16 | 19.94 | 25.58 | 27.51 | 27.73 | 28.59 |
| Operating CF / share | 5.34 | 4.05 | 3.29 | 5.54 | 9.33 | 9.02 | 9.87 | 9.68 | 9.79 |
| Free cash flow / share | 3.28 | 1.37 | 0.12 | 2.58 | 6.59 | 4.37 | 4.47 | 4.73 | 4.66 |
| Dividends / share | 2.19 | 2.20 | 1.68 | 1.00 | 1.00 | 1.95 | 2.18 | 2.13 | 2.17 |
| Payout ratio | +150.69% | -380.39% | -56.13% | +34.20% | +15.61% | +78.31% | +81.69% | +79.07% | +77.56% |
| Retention ratio | -50.69% | +480.39% | +156.13% | +65.80% | +84.39% | +21.69% | +18.31% | +20.93% | +22.44% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | -1.98% | -1.46% | +57.60% | +19.08% | +29.18% | +5.99% | +0.99% | +4.14% | +12.74% |
| Gross profit · YoY | — | -9.76% | -45.43% | +449.06% | +71.22% | -16.59% | +0.94% | +5.83% | +3.95% | +19.96% |
| Profit | ||||||||||
| Operating income · YoY | — | -15.40% | -59.90% | +784.31% | +80.11% | -23.92% | +8.10% | +1.85% | +2.39% | +21.13% |
| EBITDA · YoY | — | -40.79% | -43.39% | +323.36% | +66.83% | -13.40% | +5.05% | -0.97% | +8.35% | +11.04% |
| Net income · YoY | — | -139.37% | -449.24% | +232.80% | +111.62% | -60.82% | +5.57% | +1.19% | +5.10% | +13.08% |
| Operating | ||||||||||
| EBIT · YoY | — | -87.19% | -1113.07% | +378.30% | +108.65% | -46.75% | +7.83% | +0.83% | +1.76% | +20.48% |
| R&D · YoY | — | +48.70% | -12.66% | -1.50% | -15.74% | +98.87% | +7.32% | +2.08% | +0.74% | +11.37% |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | -139.73% | -417.24% | +195.33% | +124.13% | +60.45% | +11.01% | +9.30% | -4.44% | +30.02% |
| EPS · basic · YoY | — | -139.73% | -417.24% | +195.33% | +124.13% | +58.70% | +12.33% | +10.41% | -5.25% | +30.06% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $6.3B | $6.13B | $9.44B | $8.97B | $5.71B | $15.11B | $15.95B | $15.56B | $15.9B |
| Net debt | $1.31B | $3.26B | $6.43B | $5.35B | -$1.94B | $7.67B | $7.79B | $7.48B | $7.68B |
| Net debt / EBITDA | 0.24 | 0.99 | 3.46 | 0.68 | -0.15 | 0.68 | 0.65 | 0.63 | 0.60 |
| Debt / equity | 0.29 | 0.31 | 0.32 | 0.30 | 0.17 | 0.28 | 0.27 | 0.26 | 0.27 |
| Debt / assets | +15.54% | +15.93% | +17.00% | +15.92% | +10.00% | +15.25% | +15.07% | +15.21% | +14.28% |
| Equity / assets | +53.89% | +50.76% | +52.62% | +53.43% | +59.60% | +54.99% | +55.42% | +58.19% | +53.16% |
| Coverage | |||||||||
| EBITDA / interest expense | 20.84 | 14.46 | 7.49 | 20.43 | 43.60 | 21.24 | 21.16 | 20.91 | 21.54 |
| Operating income / interest | 7.20 | 7.14 | 2.62 | 14.93 | 34.40 | 14.72 | 15.09 | 15.34 | 14.93 |
| Interest expense | $266M | $227M | $248M | $385M | $301M | $535.12M | $564.16M | $565.3M | $594.8M |
| Liquidity | |||||||||
| Current ratio | 2.90 | 2.23 | 1.25 | 1.63 | 2.29 | — | — | — | — |
| Quick ratio | 2.04 | 1.52 | 0.71 | 0.62 | 1.75 | — | — | — | — |
| Cash ratio | 1.88 | 0.98 | 0.50 | 0.48 | 1.34 | — | — | — | — |
| Working capital | $5.04B | $3.59B | $1.51B | $4.73B | $7.35B | — | — | — | — |
| Working capital / revenue | +41.36% | +30.04% | +12.86% | +25.50% | +33.28% | — | — | — | — |
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
Valuation
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| P / E | — | — |
| P / B | — | — |
| EV / EBITDA | — | — |
| EV / Sales | 4.91x | 2.59x |
| Earnings yield | 6.4% | 7.8% |
| FCF yield | 6.6% | 6.9% |
Returns
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
| ROE | 20.9% | 11.2% |
| ROA | 12.4% | 5.9% |
| ROIC | 12.2% | 8.1% |
Leverage & liquidity
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Debt / equity | — | — |
| Net debt / EBITDA | -0.15 | 0.68 |
| Interest coverage | — | — |
| Current ratio | 2.29x | 1.63x |
| Quick ratio | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).